With a campus in Welwyn Garden City, Hertfordshire, our pharmaceutical business plays a signiﬁcant role in advancing healthcare in the UK. Our UK site is a key part of Roche’s global research and development (R&D) programme, the largest of any healthcare company in the world. A key reason for this is the wealth of scientific talent in the UK, and the key partnerships that we have with universities, the NHS, regulators and Government. In 2020, we invested over £400 million into UK research, which equates to 8.5% of the total UK government spending on healthcare research.
Our passion for improving the lives of people across the UK is reflected in the next stage of the journey in developing new treatments - taking them from the lab to the real world. Since 2018, every single new Roche medicine that we’ve brought to market in the UK is available on the NHS.
Roche UK Impact study
March 2022 / M-GB-00006690
M-GB-00011728 Date of Preparation March 2023
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.